StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
NASDAQ XXII opened at $0.10 on Friday. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. 22nd Century Group has a 1 year low of $0.08 and a 1 year high of $5.28. The company has a market capitalization of $4.61 million, a PE ratio of 0.00 and a beta of 1.45. The company has a fifty day moving average of $0.14 and a two-hundred day moving average of $0.51.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The company had revenue of $5.95 million during the quarter.
Hedge Funds Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Recommended Stories
- Five stocks we like better than 22nd Century Group
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- 5 discounted opportunities for dividend growth investors
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What Investors Need to Know to Beat the Market
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.